MedTrace Logo

Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis

NCT05722548 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-02-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of rectal indomethacin in prevention of post-pancreatectomy acute pancreatitis.

Conditions

  • Pancreatectomy

Interventions

DRUG

Indomethacin suppository

100mg of Indomethacin Suppository sigle dose at the time of induction of anesthesia

OTHER

Standard Medical Treatment

Standard Medical Treatment

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Yingbin Liu, PHD · RenJi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-12-31
Completion
2024-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05722548 on ClinicalTrials.gov